The Transmissible Spongiform Encephalopathies Advisory Committee was terminated on June 9, 2016. For more information, please refer to the Federal Register Notice FR Document Number 2016-13705 that was published on June 9, 2016.
All topics previously brought before the terminated Transmissible Spongiform Encephalopathies Advisory Committee will now be addressed by the Food and Drug Administration's other advisory committees, such as the Blood Products Advisory Committee (BPAC).
- FDA Advisory Committee Information Line
- (301-443-0572 in the Washington DC area)
Please call the Information Line for up-to-date information on this meeting.